ID: ALA4536593

Max Phase: Preclinical

Molecular Formula: C24H24N2O2

Molecular Weight: 372.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(C)c2[nH]c(=O)c3ccccc3c2c1-c1ccc([C@@H](C)CN)cc1

Standard InChI:  InChI=1S/C24H24N2O2/c1-14-12-20(28-3)21(17-10-8-16(9-11-17)15(2)13-25)22-18-6-4-5-7-19(18)24(27)26-23(14)22/h4-12,15H,13,25H2,1-3H3,(H,26,27)/t15-/m0/s1

Standard InChI Key:  FIPQTWQDFHBEHR-HNNXBMFYSA-N

Associated Targets(Human)

PDZ-binding kinase 995 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.1838AlogP: 4.73#Rotatable Bonds: 4
Polar Surface Area: 68.11Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 4.52CX LogD: 2.22
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -0.05

References

1. Hu QF, Gao TT, Shi YJ, Lei Q, Liu ZH, Feng Q, Chen ZJ, Yu LT..  (2019)  Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK.,  162  [PMID:30453248] [10.1016/j.ejmech.2018.11.007]

Source